The U.S. Food and Drug Administration approved Eli Lilly's Reyvow (lasmiditan) for the acute treatment of migraines.
More promising developments in the management and prevention of migraines.
I personally tried Ajovy and it didn't do too much for me and now I'm taking Emgality. The jury is still out on that verdict...need a few more months to go by before any conclusions can be made.
I'm just excited that people are actively trying to find medical treatments for this disease. Keep 'em coming!

















